“Patient- and Clinician-Reported Outcomes of Tirbanibulin 1% in the Treatment of Actinic Keratosis on the Face and Scalp (PROAK Study)”. SKIN The Journal of Cutaneous Medicine, vol. 7, no. 6, Nov. 2023, p. s262, https://doi.org/10.25251/skin.7.supp.262.